Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis: A Matched Cohort Study
Conclusions:
Patients with HCC and HH can achieve comparable survival rates following curative or LRT modalities to other liver diseases. The BCLC staging system accurately stratifies survival and excellent 5-year survival is possible following LT in selected patients.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cardiology | Gastroenterology | Genetics | Heart | Heart Disease | Heart Transplant | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Study | Transplants | Urology & Nephrology